Ronaghi

Dr. Mostafa Ronaghi is an experienced entrepreneur and well-published scientist. He is an inventor of Pyrosequencing technology and co-founded Pyrosequencing AB in 1997 (renamed to Biotage in 2003), a genomics company that develops and markets Pyrosequencing systems and consumables. Pyrosequencing AB had a successful IPO in June 2000 on the Stockholm Stock Exchange and has since acquired three companies. Dr. Ronaghi co-invented Molecular Inversion Probe assay and co-founded ParAllele BioScience in November 2001. ParAllele developed and marketed a highly multiplexed technology for genetic testing. ParAllele was acquired by Affymetrix in May 2005. In 2005, co-founded NextBio, a search engine for life science data. He is currently a principal investigator at Stanford University focusing on developing novel tools for molecular diagnostics. He earned his Ph.D. from the Royal Institute of Technology in Sweden. Dr. Ronaghi holds more than 20 pending and issued patents and has written more than 50 peer-reviewed publications in journals and books.